市場調查報告書

全球神經刺激器市場機會分析/行業預測(2019-2026):按設備類型/應用

Neurostimulation Devices Market by Device Type Application: Global Opportunity Analysis and Industry Forecast, 2019-2026

出版商 Allied Market Research 商品編碼 948582
出版日期 內容資訊 英文 176 Pages
商品交期: 2-3個工作天內
價格
全球神經刺激器市場機會分析/行業預測(2019-2026):按設備類型/應用 Neurostimulation Devices Market by Device Type Application: Global Opportunity Analysis and Industry Forecast, 2019-2026
出版日期: 2020年05月01日內容資訊: 英文 176 Pages
簡介

預計全球神經刺激器市場在2018年將達到43.875億美元,到2026年將達到112.574億美元,從2019年到2026年的複合年增長率為12.5%。它是神經刺激器特別用於治療神經系統疾病,例如癲癇,慢性疼痛,帕金森氏病,抑鬱症和其他疾病。神經技術的進步為受精神和神經疾病影響的患者提供了緩解。與生活方式相關的疾病(例如抑鬱症和慢性疼痛)的流行,神經系統疾病的增加以及對神經元研究和開發的投資是全球神經刺激器市場增長的一些驅動因素。此外,對微創外科手術的需求不斷增長,採用技術先進的產品以及易患神經系統疾病(例如癲癇,帕金森氏病,阿爾茨海默氏病和慢性疼痛)的老年人口激增也為市場做出了貢獻。促進成長神經刺激器市場增長的主要障礙是過敏反應,將神經刺激器植入體內的副作用以及設備成本增加。然而,諸如藥物治療和手術之類的其他治療選擇的可獲得性限制了市場的增長。

此報告調查了全球神經刺激器市場,並提供了市場概況和動態,按細分市場/區域進行的市場規模分析和預測以及主要公司的概況。

第1章簡介

第2章執行摘要

第3章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資口袋
    • 主要成功策略
  • 市場動態
    • 主持人
      • 神經病患病率上升
      • 增加對神經系統疾病研發的投資
    • 抑制因子
      • 與神經刺激有關的不良反應和風險
    • 市場機會
      • 將神經刺激劑用於新適應症

第4章按設備類型劃分的神經刺激器市場

  • 概述
    • 市場規模和預測
  • 脊髓刺激器
    • 主要市場趨勢,增長因素,機遇
    • 市場規模和地區預測
    • 國家市場分析
  • 深層腦刺激器
  • S神經刺激器 迷走神經刺激器
  • 其他

第5章神經刺激器應用市場

  • 概述
    • 市場規模和預測
  • 疼痛管理
    • 市場規模和地區預測
    • 國家市場分析
  • 聽力損失
  • 尿失禁
  • 帕金森氏病
  • 癲癇病
  • 其他

第6章按地區劃分的全球神經刺激器市場

  • 概述
    • 市場規模和預測
  • 北美
    • 主要市場趨勢和機遇
    • 市場規模和預測:按設備類型
    • 市場規模和按應用預測
    • 市場規模和國家預測
      • 美國市場規模和設備類型預測
      • 美國市場規模和按應用預測
      • 加拿大市場規模和設備類型預測
      • 加拿大市場規模和按應用預測
      • 墨西哥市場規模和按設備類型預測
      • 墨西哥市場規模和按應用預測
  • 歐洲
    • 主要市場趨勢和機遇
    • 市場規模和預測:按設備類型
    • 市場規模和按應用預測
    • 市場規模和國家預測
      • 德國市場規模和設備類型預測
      • 德國市場規模和按應用預測
      • 法國市場規模和設備類型預測
      • 法國市場規模和按應用預測
      • 英國市場規模和設備類型預測
      • 英國市場規模和按應用預測
      • 意大利市場規模和設備類型預測
      • 意大利市場規模和按應用預測
      • 其他歐洲市場規模和按設備類型預測
      • 其他歐洲市場規模和按應用預測
  • 亞太地區
    • 主要市場趨勢和機遇
    • 市場規模和預測:按設備類型
    • 市場規模和按應用預測
    • 市場規模和國家預測
      • 日本市場規模和按設備類型預測
      • 日本市場規模和按應用預測
      • 中國市場規模及設備類型預測
      • 中國市場規模及應用預測
      • 印度市場規模和按設備類型預測
      • 印度市場規模和按應用預測
      • 澳大利亞市場規模和設備類型預測
      • 澳大利亞市場規模和按應用預測
      • 其他亞太市場規模和按設備類型預測
      • 其他亞太市場規模和按應用預測
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 市場規模和預測:按設備類型
    • 市場規模和按應用預測
    • 市場規模和國家預測
      • 巴西市場規模和按設備類型預測
      • 巴西市場規模和按應用預測
      • 沙特阿拉伯市場規模和按設備類型預測
      • 沙特阿拉伯市場規模和按應用預測
      • 南非市場規模和按設備類型預測
      • 南非市場規模和按應用預測
      • 其他LAMEA市場規模和按設備類型預測
      • 其他LAMEA市場規模和按應用預測

第7章公司簡介

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • ElectroCore Inc.
  • EndoStim Inc.
  • Medtronic plc
  • NeuroPace Inc.
  • Nevro Corporation
  • Neuronetics Inc.
  • NeuroSigma Inc.
  • Synapse Biomedical Inc.
目錄
Product Code: A05193

Title:
Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026.

The global neurostimulation devices market was valued at $4,387.5 million in 2018 and is projected to reach $11,257.4 million by 2026, registering a CAGR of 12.5% from 2019 to 2026. Neurostimulation is an electrical process of stimulating, inhibiting, modifying, regulating, and altering the activity in the central, autonomous, or peripheral nervous system in the human body. Neurostimulation devices send electrical impulse near to the spine region wherein these signals block the pain signals from reaching the brain. These devices deliver electrical stimulation to the patient's brain, spinal cord, and peripheral nervous system. Neurostimulation devices are particularly used for the treatment of neurological disorders such as epilepsy, chronic pain, Parkinson's disease, depression, and other diseases. Advancements in the neurological technologies is delivering relief to the patients affected by psychiatric and neurological disorders.

According to the data published by WHO, there are around 50 million cases of dementia across the globe among which 60-70% are Alzheimer's and 10 million are added every year. Dementia is the fifth leading cause of death worldwide. Furthermore, the incidence rate for Parkinson's disease is 4.5-19 per 100,000 population every year.

Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are some of the factors that drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. The major barriers for the growth of the neurostimulation devices market are side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.

The neurostimulation devices market is classified on the basis of device type, application, and region. Based on device type, the neurostimulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. On the basis of application, the market is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

The key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Device Type

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

By Application

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • Aleva neurotherapeutics SA
  • Boston scientific corporation
  • ElectroCore Inc.
  • EndoStim Inc.
  • Medtronic plc
  • NeuroPace Inc.
  • Nevro corporation
  • Neuronetics Inc.
  • NeuroSigma, Inc.
  • Synapse Biomedical Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Market dynamics
    • 3.3.1.Drivers
      • 3.3.1.1.Rise in prevalence of neurological disorders
      • 3.3.1.2.Increase in investments in R&D for neurological disorders
    • 3.3.2.Restraints
      • 3.3.2.1.Adverse effects and risks associated with neurostimulation devices
    • 3.3.3.Opportunities
      • 3.3.3.1.Use of neurostimulators for new indications

CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Spinal Cord Stimulators
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Deep Brain Stimulators
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Sacral Nerve Stimulators
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country
  • 4.5.Vagus Nerve Stimulators
    • 4.5.1.Key market trends, growth factors, and opportunities
    • 4.5.2.Market size and forecast, by region
    • 4.5.3.Market analysis, by country
  • 4.6.Others
    • 4.6.1.Key market trends, growth factors, and opportunities
    • 4.6.2.Market size and forecast, by region
    • 4.6.3.Market analysis, by country

CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Pain Management
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Hearing Loss
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Urinary Incontinence
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Parkinson's Disease
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country
  • 5.6.Epilepsy
    • 5.6.1.Market size and forecast, by region
    • 5.6.2.Market analysis, by country
  • 5.7.Others
    • 5.7.1.Market size and forecast, by region
    • 5.7.2.Market analysis, by country

CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.Market size and forecast, by device type
    • 6.2.3.Market size and forecast, by application
    • 6.2.4.Market size and forecast, by country
      • 6.2.4.1.U.S. market size and forecast, by device type
      • 6.2.4.2.U.S. market size and forecast, by application
      • 6.2.4.3.Canada market size and forecast, by device type
      • 6.2.4.4.Canada market size and forecast, by application
      • 6.2.4.5.Mexico market size and forecast, by device type
      • 6.2.4.6.Mexico market size and forecast, by application
  • 6.3.Europe
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Market size and forecast, by device type
    • 6.3.3.Market size and forecast, by application
    • 6.3.4.Market size and forecast, by country
      • 6.3.4.1.Germany market size and forecast, by device type
      • 6.3.4.2.Germany market size and forecast, by application
      • 6.3.4.3.France market size and forecast, by device type
      • 6.3.4.4.France market size and forecast, by application
      • 6.3.4.5.UK market size and forecast, by device type
      • 6.3.4.6.UK market size and forecast, by application
      • 6.3.4.7.Italy market size and forecast, by device type
      • 6.3.4.8.Italy market size and forecast, by application
      • 6.3.4.10.Rest of Europe market size and forecast, by device type
      • 6.3.4.11.Rest of Europe market size and forecast, by application
  • 6.4.Asia-Pacific
    • 6.4.1.Key market trends and opportunities
    • 6.4.2.Market size and forecast, by device type
    • 6.4.3.Market size and forecast, by application
    • 6.4.4.Market size and forecast, by country
      • 6.4.4.1.Japan market size and forecast, by device type
      • 6.4.4.2.Japan market size and forecast, by application
      • 6.4.4.3.China market size and forecast, by device type
      • 6.4.4.4.China market size and forecast, by application
      • 6.4.4.5.India market size and forecast, by device type
      • 6.4.4.6.India market size and forecast, by application
      • 6.4.4.7.Australia market size and forecast, by device type
      • 6.4.4.8.Australia market size and forecast, by application
      • 6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type
      • 6.4.4.10.Rest of Asia-Pacific market size and forecast, by application
  • 6.5.LAMEA
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.Market size and forecast, by device type
    • 6.5.3.Market size and forecast, by application
    • 6.5.4.Market size and forecast, by country
      • 6.5.4.1.Brazil market size and forecast, by device type
      • 6.5.4.2.Brazil market size and forecast, by application
      • 6.5.4.3.Saudi market size and forecast, by device type
      • 6.5.4.4.Saudi market size and forecast, by application
      • 6.5.4.5.South Africa market size and forecast, by device type
      • 6.5.4.6.South Africa market size and forecast, by application
      • 6.5.4.7.Rest of LAMEA market size and forecast, by device type
      • 6.5.4.8.Rest of LAMEA market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

  • 7.1.Abbott Laboratories
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product portfolio
    • 7.1.5.Business performance
    • 7.1.6.Key strategic moves and developments
  • 7.2.Aleva Neurotherapeutics SA
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
    • 7.2.5.Key strategic moves and developments
  • 7.3.Boston Scientific Corporation
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
    • 7.3.6.Key strategic moves and developments
  • 7.4.ElectroCore Inc.
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
  • 7.5.EndoStim Inc.
    • 7.5.1.Company overview
    • 7.5.2.Operating business segments
    • 7.5.3.Product portfolio
  • 7.6.Medtronic plc
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance

Source: Corporate Publications and AMR Analysis

  • 7.7.NeuroPace Inc.
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product portfolio
    • 7.7.5.Key strategic moves and developments
  • 7.8.Nevro Corporation
    • 7.8.1.Company overview
    • 7.8.2.Operating business segment
    • 7.8.3.Product portfolio
    • 7.8.4.Business performances
    • 7.8.5.Key strategic moves and developments
  • 7.9.Neuronetics Inc.
    • 7.9.1.Company overview
    • 7.9.2.Neuronetics: Company Snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
    • 7.9.6.Key strategic moves and developments
  • 7.10.NeuroSigma Inc.
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.Key strategic moves and developments
  • 7.11.Synapse Biomedical Inc.
    • 7.11.1.Company overview
    • 7.11.2.Company snapshot
    • 7.11.3.Operating business segments
    • 7.11.4.Product portfolio
    • 7.11.5.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE, 2018-2026 ($MILLION)
  • TABLE 02.NEUROSTIMULATION DEVICES MARKET, FOR SPINAL CORD STIMULATORS BY REGION, 2018-2026 ($MILLION)
  • TABLE 03.NEUROSTIMULATION DEVICES MARKET, FOR DEEP BRAIN STIMULATORS BY REGION, 2018-2026 ($MILLION)
  • TABLE 04.NEUROSTIMULATION DEVICES MARKET, FOR SACRAL NERVE STIMULATORS BY REGION, 2018-2026 ($MILLION)
  • TABLE 05.NEUROSTIMULATION DEVICES MARKET, FOR VAGUS NERVE STIMULATORS BY REGION, 2018-2026 ($MILLION)
  • TABLE 06.NEUROSTIMULATION DEVICES MARKET, FOR OTHERS BY REGION, 2018-2026 ($MILLION)
  • TABLE 07.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2018-2026 ($MILLION)
  • TABLE 08.NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT, BY REGION, 2018-2026 ($MILLION)
  • TABLE 09.NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 10.NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY REGION, 2018-2026 ($MILLION)
  • TABLE 11.NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018-2026 ($MILLION)
  • TABLE 12.NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY REGION, 2018-2026 ($MILLION)
  • TABLE 13.NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2018-2026 ($MILLION)
  • TABLE 14.GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2018-2026, ($MILLION)
  • TABLE 15.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 16.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 17.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
  • TABLE 18.U.S. NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 19.U.S. NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 20.CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 21.CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 22.MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 23.MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 24.EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 25.EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 26.EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
  • TABLE 27.GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 28.GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 29.FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 30.FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 31.UK NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 32.UK NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 33.ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 34.ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 35.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 36.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 37.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 38.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 39.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
  • TABLE 40.JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 41.JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 42.CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 43.CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 44.INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 45.INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 46.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 47.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 48.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 49.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 50.LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 51.LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 52.LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
  • TABLE 53.BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 54.BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 55.SAUDI NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 56.SAUDI NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 57.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 58.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 59.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
  • TABLE 60.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
  • TABLE 61.ABBOTT: COMPANY SNAPSHOT
  • TABLE 62.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 63.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 64.Aleva neurotherapeutics: company Snapshot
  • TABLE 65.ALEVA NEUROTHERAPEUTICS: OPERATING SEGMENT
  • TABLE 66.ALEVA NEUROTHERAPEUTICS: PRODUCT PORTFOLIO
  • TABLE 68.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 69.BOSTON: PRODUCT PORTFOLIO
  • TABLE 70.ELECTROCORE INC: COMPANY SNAPSHOT
  • TABLE 71.ELCTROCORE: OPERATING SEGMENTS
  • TABLE 72.ELECTROCORE INC: PRODUCT PORTFOLIO
  • TABLE 73.ENDOSTIM INC: OPERATING SEGMENT
  • TABLE 74.ENDOSTIM INC: PRODUCT PORTFOLIO
  • TABLE 75.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 76.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 77.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 78.NEUROPACE INC.: COMPANY SNAPSHOT
  • TABLE 79.NEUROPACE INC.: OPERATING SEGMENTS
  • TABLE 80.NEUROPACE INC.: PRODUCT PORTFOLIO
  • TABLE 81.NEVRO CORPORATION.: OPERATING SEGMENTS
  • TABLE 82.NEVRO CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 83.NEURONETICS: OPERATING SEGMENT
  • TABLE 84.NEURONETICS : PRODUCT PORTFOLIO
  • TABLE 85.NEUROSIGMA INC: COMPANY SNAPSHOT
  • TABLE 86.NEUROSIGMA INC COMPANY: PRODUCT SEGMENT
  • TABLE 87.NEUROSIGMA INC: PRODUCT PORTFOLIO
  • TABLE 88.SYNAPSE BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 89.SYNAPSE BIOMEDICAL: OPERATING SEGMENT
  • TABLE 90.SYNAPSE BIOMEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.NEUROSTIMULATION DEVICES MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
  • FIGURE 06.TOP IMPACTING FACTORS
  • FIGURE 07.NEUROSTIMULATION DEVICES, FOR SPINAL CORD STIMULATORS BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 08.NEUROSTIMULATION DEVICES, FOR DEEP BRAIN STIMULATORS BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 09.NEUROSTIMULATION DEVICES, FOR SACRAL NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 10.NEUROSTIMULATION DEVICES, FOR VAGUS NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 11.NEUROSTIMULATION DEVICES, FOR OTHERS BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 12.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 13.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 18.ABBOTT LABORATORIES: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 19.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2018(%)
  • FIGURE 20.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2018(%)
  • FIGURE 21.BOSTON: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 22.BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 23.BOSTON: REVENUE SHARE BY REGION, BY 2018%
  • FIGURE 24.ELECTROCORE.: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 25.ELECTROCORE INC.: REVENUE SHARE BY REGION,2018 %
  • FIGURE 26.MEDTRONIC: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 27.MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 28.MEDTRONIC PLC: REVENUE SHARE BY REGION, 2018(%)
  • FIGURE 29.NEVRO CORPORATION.: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 30.NEVRO CORPORATION.: REVENUE SHARE BY REGION,2018 %
  • FIGURE 31.NEURONETICS: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 32.NEURONETICS: REVENUE SHARE BY REGION, 2018(%)